THE CONAFAY GROUP, LLC

Lobbying for ELUSYS THERAPEUTICS, INC · A therapeutics company that manufactures novel antitoxins for health security needs.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Advocacy for medical countermeasure funding and support.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.